Akari Therapeutics Receives FDA Fast Track Designation for Nomacopan for Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)

Stock Information for Akari Therapeutics Plc

Loading

Please wait while we load your information from QuoteMedia.